Journey Medical Corp (DERM) - Total Liabilities
Based on the latest financial reports, Journey Medical Corp (DERM) has total liabilities worth $62.74 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check DERM cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Journey Medical Corp - Total Liabilities Trend (2014–2025)
This chart illustrates how Journey Medical Corp's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Journey Medical Corp total assets.
Journey Medical Corp Competitors by Total Liabilities
The table below lists competitors of Journey Medical Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bank Capital Indonesia Tbk
JK:BACA
|
Indonesia | Rp18.80 Trillion |
|
Daios Plastics S.A.
AT:DAIOS
|
Greece | €107.87 Million |
|
AirBoss of America Corp.
TO:BOS
|
Canada | CA$171.05 Million |
|
Muhak Co. Ltd
KO:033920
|
Korea | ₩105.07 Billion |
|
NH SPAC 2
KQ:206640
|
Korea | ₩37.46 Billion |
|
Diamond Building Products Public Company Limited
BK:DRT
|
Thailand | ฿1.67 Billion |
|
Atrem S.A.
WAR:ATR
|
Poland | zł152.29 Million |
|
Tenaya Therapeutics Inc
NASDAQ:TNYA
|
USA | $22.11 Million |
Liability Composition Analysis (2014–2025)
This chart breaks down Journey Medical Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Journey Medical Corp (DERM) balance sheet quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.79 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.97 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.66 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Journey Medical Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Journey Medical Corp (2014–2025)
The table below shows the annual total liabilities of Journey Medical Corp from 2014 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $62.74 Million | +4.26% |
| 2024-12-31 | $60.17 Million | +6.50% |
| 2023-12-31 | $56.50 Million | -35.93% |
| 2022-12-31 | $88.18 Million | +59.62% |
| 2021-12-31 | $55.24 Million | +32.75% |
| 2020-12-31 | $41.61 Million | +33.78% |
| 2019-12-31 | $31.11 Million | -91.20% |
| 2018-12-31 | $353.36 Million | -14.05% |
| 2017-12-31 | $411.14 Million | +530.29% |
| 2016-12-31 | $65.23 Million | +78.93% |
| 2015-12-31 | $36.46 Million | +47.95% |
| 2014-12-31 | $24.64 Million | -- |
About Journey Medical Corp
Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat sev… Read more